Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy | Molecular Cancer | Full Text
Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy | Molecular Cancer | Full Text
PD-1/ PD-L1 blockade as a novel treatment for colorectal cancer - ScienceDirect
Predictive biomarkers in PD-1/PD-L1 checkpoint blockade immunotherapy - ScienceDirect
Identification and Validation of a PD-L1 Binding Peptide for Determination of PDL1 Expression in Tumors | Scientific Reports
Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy | Molecular Cancer | Full Text
PD-L1 expression on nonclassical monocytes reveals their origin and immunoregulatory function | Science Immunology
Tumor cell-intrinsic PD-1 receptor is a tumor suppressor and mediates resistance to PD-1 blockade therapy | PNAS
Learning from PD-1 Resistance: New Combination Strategies: Trends in Molecular Medicine
Collagen promotes anti-PD-1/PD-L1 resistance in cancer through LAIR1-dependent CD8+ T cell exhaustion | Nature Communications
Cancer immunotherapy and the PD-1/PD-L1 checkpoint pathway | Abcam
Role of PD-1 during effector CD8 T cell differentiation | PNAS
Programmed death ligand-1 (PD-L1) as a predictive marker for immunotherapy in solid tumours: a guide to immunohistochemistry implementation and interpretation - Pathology
PD-1-high TILs: a predictive biomarker for ICB in lung cancer
Anti-PDL-1 Antibody Treatment Reduces Expression of the Exhaustion Marker PD -1 in T Cells | Biocompare Antibody Review
Restriction of PD-1 function by cis-PD-L1/CD80 interactions is required for optimal T cell responses | Science
Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors | Molecular Cancer | Full Text
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity | Nature
The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies | Nature Immunology
Release the B7.1! Anti-PD-L1 breaks PD-L1's grip
IVD Antibody Development Services for PD-L1 Marker - Creative Biolabs
